Wednesday, April 27, 2016 9:33:33 AM
You are correct that it cannot be sold in the US, but the question is why not? The answer is because it might be a drug and requires further study, not because it is a scam product.
You ask "2--If they have no money how do they continually pay thousands and thousands of dollars for stock promotions (failed ones at that)?".
Yes, there was only one stock promotion that Roth paid for, so the word "continually" is not accurate. I believe it was $15k to be precise. My opinion here is this $15k is pocket change compared to paying for audited financials every quarter.
I choose to look at the bigger picture. When the clinical trials are completed in Mexico and approved by India, then sales will start on a large scale. This is the expectation. This will make the $15k look like a dime found laying on the street.
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM